 Evofem Biosciences Inc NASDAQ: EVFM shares are trading higher after the Health Resources and Services Administration HRSA and the U.S. Department of Labor issued updated guidance related to contraceptive access. The new guidance specifies that most insurers and pharmacy benefit managers PBMs must provide coverage, with no out-of-pocket costs to women, for FDA-approved contraceptive products, like Phexxi, prescribed by healthcare providers. 